Following the publication of Agronomics' FY22 (to June 22) results, we provide an overview of both FY22 and the calendar, which we believe has showcased the progress and evolution of the company's investment strategy and some significant milestones for the cellular agriculture industry as a whole. Through FY22, Agronomics invested c£42m into its portfolio, and additionally formed two new companies, while in November 2022, the FDA announced it had completed its first pre-market consultation for a ....
